Accueil > Actualités > Événements Genopole > 2009 > Biomarkers Conference 2009

Biomarkers Conference 2009

Program

8:00	Registration
8:30	Opening Address - André Capron, Academician of Medecine
9:00	Alain Huriez, Chief Executive Officer TcLand Expression
SESSION 1 – RARE DISEASES CHAIRMAN : Daniel Scherman
9:15	Thomas Voit, the Myology Institute, France Biomarkers in Duchenne Muscular Dystrophy : defining what is known and exploring the unknown
9:45	Marc Peschanski, Director of Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-STEM), France Pluripotent stem cells as a tool for drug discovery in monogenic diseases
10:15	Brenda Wong, Child neurology, Cincinnati Children’s Hospital Medical Center, USA Gene expression profiling (transcriptomics) of blood in Duchenne Muscular Dystrophy _
10:45	Coffee break
SESSION 2 – POLYFACTORIAL DISEASES CHAIRMAN : Guillaume Charpentier
11:15	Nabila Bouatia-Naji, Institut Pasteur de Lille, France From Genomics to new biomarkers for diabetes and obesity
11:45	Pierre Miossec, Centre de Rhumatologie, CHU Lyon, France Markers of disease heterogeneity and response to treatment in rheumatoid arthritis
SESSION 3 – NEGLECTED DISEASES CHAIRMAN : Yves Champey
12:15	Piero Olliaro, World Health Organization, Switzerland Challenges with biomarkers for neglected tropical diseases
12:45	Robert S. Wallis, Pfizer Global Research & Development Biomarkers for tuberculosis
13:15	Cocktail lunch
SESSION 4 – NEW TECHNICAL TOOLS CHAIRMAN : Jérôme Garin
14:30	Bruno Domon, Institute of Molecular Systems Biology, ETH Zurich Novel mass spectrometry-based approaches applied to biomarker discovery and evaluation
15:00	David Cumming, University of Glasgow, UK Integrated Sensors
15:30	Michel Werner, CEA The hight throughput sequencing revolution in functional genomics : Application to the study of transcription
SESSION 5 – STATISTICS, BIO-INFORMATICS CHAIRMAN : Laurent Becquemont
16:00	Alessandra Cervino, Vice-president Biostatistics & Bioinformatics TCLand Expression A data integrated approach to biomarker discovery
16:30	Alessandro Quattrone, Center for integrative biology, Trento, Italy Why biomarker identification by transcriptome analysis is so difficult
17:00	Coffee break
SESSION 6 – HEALTH POLICY CHAIRMAN : Didier Caizergues
17:30	Isabelle Durand-Zaleski, Henri Mondor Hospital, France The use of biomarkers for priority setting and allocation of healthcare resources
18:00	Jean-Claude Ghislain, AFSSAPS, France Current regulatory framework of in vitro diagnostic medical devices, perspectives and accompanying innovation
18:30	Closing address – Pierre Tambourin, CEO Genopole